FDA to Remove Black-Box Warnings From Three More Menopause Estrogen Patches

The FDA said October 30, 2026, three more menopause estrogen patches will no longer carry black-box warnings, boxed alerts, for heart disease, breast cancer and dementia. No outside expert panel was convened, and officials said evidence could come later. FDA's Sarah Ibrahim said the warnings overstated risk in some cases. Yale's Reshma Ramachandran said blanket removal can mislead.